Cargando…
Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types
This cross-sectional study evaluates the stipulations of coverage under commercial, health insurance exchange, Veterans Affairs, Medicare, Medicaid, or other insurance for canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin.
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796944/ https://www.ncbi.nlm.nih.gov/pubmed/35977296 http://dx.doi.org/10.1001/jamahealthforum.2021.4205 |
| _version_ | 1784641430352822272 |
|---|---|
| author | Tummalapalli, Sri Lekha Montealegre, Julio Lamprea Warnock, Neil Green, Michael Ibrahim, Said A. Estrella, Michelle M. |
| author_facet | Tummalapalli, Sri Lekha Montealegre, Julio Lamprea Warnock, Neil Green, Michael Ibrahim, Said A. Estrella, Michelle M. |
| author_sort | Tummalapalli, Sri Lekha |
| collection | PubMed |
| description | This cross-sectional study evaluates the stipulations of coverage under commercial, health insurance exchange, Veterans Affairs, Medicare, Medicaid, or other insurance for canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin. |
| format | Online Article Text |
| id | pubmed-8796944 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Medical Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87969442022-02-07 Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types Tummalapalli, Sri Lekha Montealegre, Julio Lamprea Warnock, Neil Green, Michael Ibrahim, Said A. Estrella, Michelle M. JAMA Health Forum Research Letter This cross-sectional study evaluates the stipulations of coverage under commercial, health insurance exchange, Veterans Affairs, Medicare, Medicaid, or other insurance for canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin. American Medical Association 2021-12-17 /pmc/articles/PMC8796944/ /pubmed/35977296 http://dx.doi.org/10.1001/jamahealthforum.2021.4205 Text en Copyright 2021 Tummalapalli SL et al. JAMA Health Forum. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
| spellingShingle | Research Letter Tummalapalli, Sri Lekha Montealegre, Julio Lamprea Warnock, Neil Green, Michael Ibrahim, Said A. Estrella, Michelle M. Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types |
| title | Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types |
| title_full | Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types |
| title_fullStr | Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types |
| title_full_unstemmed | Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types |
| title_short | Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types |
| title_sort | coverage, formulary restrictions, and affordability of sodium-glucose cotransporter 2 inhibitors by us insurance plan types |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796944/ https://www.ncbi.nlm.nih.gov/pubmed/35977296 http://dx.doi.org/10.1001/jamahealthforum.2021.4205 |
| work_keys_str_mv | AT tummalapallisrilekha coverageformularyrestrictionsandaffordabilityofsodiumglucosecotransporter2inhibitorsbyusinsuranceplantypes AT montealegrejuliolamprea coverageformularyrestrictionsandaffordabilityofsodiumglucosecotransporter2inhibitorsbyusinsuranceplantypes AT warnockneil coverageformularyrestrictionsandaffordabilityofsodiumglucosecotransporter2inhibitorsbyusinsuranceplantypes AT greenmichael coverageformularyrestrictionsandaffordabilityofsodiumglucosecotransporter2inhibitorsbyusinsuranceplantypes AT ibrahimsaida coverageformularyrestrictionsandaffordabilityofsodiumglucosecotransporter2inhibitorsbyusinsuranceplantypes AT estrellamichellem coverageformularyrestrictionsandaffordabilityofsodiumglucosecotransporter2inhibitorsbyusinsuranceplantypes |